ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

Market Cap	83.20B +27.5%
Revenue (ttm)	71.13B +10.9%
Net Income	5.42B +6.3%
EPS	191.10 +6.2%
Shares Out	28.40M
PE Ratio	15.33
Forward PE	14.81
Dividend	65.00 (2.22%)
Ex-Dividend Date	Mar 30, 2026

Volume	68,700
Open	2,932.00
Previous Close	2,906.00
Day's Range	2,911.00 - 2,985.00
52-Week Range	1,920.00 - 3,045.00
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 3, 2026

About TYO:4886

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1920
• Employees: 1,632
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4886

Financial Performance

In fiscal year 2026, TYO:4886's revenue was 71.13 billion, an increase of 10.90% compared to the previous year's 64.14 billion. Earnings were 5.42 billion, an increase of 6.33%.